Wilson's disease: Resolution of MRI lesions following long-term oral zinc therapy

Acta Neurologica Scandinavica

Volumn 93, Issue 2-3, 1996, Pages 215-218

  Huang, C C ^a   Chu, N S ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Akinetic rigid syndrome; d penicillamine; MRI; Wilson's disease; Zinc sulphate

Indexed keywords

PENICILLAMINE; ZINC; ZINC SULFATE;

ADULT; ARTICLE; CASE REPORT; CONTROLLED STUDY; DYSTONIA; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE; ORAL DRUG ADMINISTRATION; WILSON DISEASE;

EID: 0029877302     PISSN: 00016314     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0404.1996.tb00203.x     Document Type: Article

References (22)

1. WALSHE JM. Penicillamine, a new oral therapy for Wilson's disease. Am J Med 1956: 21: 487-495.
2. BREWER GJ, TERRY CA, AISEN AM, HILL GM. Worsening of neurologic syndrome in patients with Wilson's disease with initial penicillamine therapy. Arch Neurol 1987: 44: 490-493.
3. WALSHE JM. The physiology of copper in man and its relation to Wilson's disease. Brain 1967: 90: 149-177.
4. STAROSTA-RUBINSTEIN S, YOUNG AB, KLUIN K, HILL G, AISEN AM, GABRIELSEN T, BREWER GJ. Clinical assessment of 31 patients with Wilson's disease. correlations with structural changes on magnetic resonance imaging. Arch Neurol 1987: 44: 365-377.
5. VEEN C, VAN DEN HAMER CJA, DE LEEUW PW. Zinc sulphate therapy for Wilson's disease after acute deterioration during treatment with low-dose d-penicillamine. J Int Med 1991: 229: 549-552.
6. WALSHE JM. Wilson's disease (hepatolenticular degeneration). In: VINKEN PJ, BRUYN GW, KLAWANS HL, eds, Handbook of clinical neurology, vol 27. Metabolic and deficiency diseases of the nervous system. Amsterdam: North Holland Publishing Co. 1976: 379-414.
7. WALSHE JM. Management of penicillamine nephropathy in Wilson's disease: a new chelating agent. Lancet 1969: ii: 1401-1402.
8. WALSHE JM. Treatment of Wilson's disease with trientine (triethylene tetramine) dihydrochloride. Lancet 1982: i: 643-647.
9. SCHOUWINK G. De Hepatocerebrale Degeneratie-Met een Onderzoek naar de Zinkstofwisseling, Thesis (with a summary in English). University of Amsterdam, Van der Wiel. Arnhem. 1961.
10. HOOGENRAAD TU, KOEVOET R, DE RUYTER KORVER EGWM. Oral zinc sulphate as long-term treatment in Wilson's disease (hepatolenticular degeneration). Eur Neurol 1979: 18: 205-211.
11. HOOGENRAAD TU, VAN HATTUM J, VAN DEN HAMER CJA. Management of Wilson's disease with zinc sulphate. experience in a series of 27 patients. J Neurol Sci 1987: 77: 137-146.
12. HOOGENRAAD TU, VAN DEN HAMER CJA, KOEVOET R, DE RUYTER KORVER EGWM. Oral zinc in Wilson's disease. Lancet 1978: ii: 1262.
13. HOOGENRAAD TU, VAN DEN HAMER CJA, VAN HATTUM J. Effective treatment of Wilson's disease with oral zinc sulphate: two case reports. Br Med J 1984: 289: 273-276.
14. PRAYER L, WIMBERGER D, KRAMER J, GRIMM G, ODER W, IMHOF H. Cranial MRI in Wilson's disease. Neuroradiology 1990: 32: 211-214.
15. THUOMAS KA, AQUILONIUS SM, BERGSTRÖM K, WESTEMARK K. Magnetic resonance imaging of the brain in Wilson's disease. Neuroradiology 1993: 35: 134-141.
16. NAZER H, BRISMAR J, AL-KAWI MZ, GUNASEKARAN TS, JORULF KH. Magnetic resonance imaging of the brain in Wilson's disease. Neuroradiology 1993: 35: 130-133.
17. HECKMANN JM, EASTMAN RW, DE VILLIERS JC, HEWLETT R. Wilson's disease: neurological and magnetic resonance imaging improvement on zinc treatment. J Neurol Neurosurg Psychiatry 1994: 57: 1273-1274.
18. GLASS JD, REICH SG, DELONG MR. Wilson's disease. Development of neurological disease after beginning penicillamine therapy. Arch Neurol 1990: 47: 595-596.
19. ROH JK, LEE TG, WIE BA, LEE SB, PARK SH, CHANG KH. Initial and follow-up brain MRI findings and correlation with the clinical course in Wilson's disease. Neurology 1994: 44: 1064-1068.
20. HITOSHI S, IWATA M, YOSHIKAWA K. Mid-brain pathology of Wilson's disease: MRI analysis of three cases. J Neurol Neurosurg Psychiatry 1991: 54: 624-626.
21. 64Cu in rats. J Nutr 1966: 88: 125-130.
22. ABDULLA M. Copper levels after oral zinc. Lancet 1979: ii: 616.